Abstract:Since their identification over twenty-five years ago, the plethora of cell-penetrating peptides (CPP) and their applications has skyrocketed. These 5 to 30 amino acid in length peptides have the unique property of breaching the cell membrane barrier while carrying cargoes larger than themselves into cells in an intact, functional form. CPPs can be conjugated to fluorophores, activatable probes, radioisotopes or contrast agents for imaging tissues, such as tumors. There is no singular mechanism for translocation of CPPs into a cell, and therefore, many CPPs are taken up by a multitude of cell types, creating the challenge of tumor-specific translocation and hindering clinical effectiveness. Varying strategies have been developed to combat this issue and enhance their diagnostic potential by derivatizing CPPs for better targeting by constructing specific cell-activated forms. These methods are currently being used to image integrin-expressing tumors, breast cancer cells, human histiocytic lymphoma and protease-secreting fibrosarcoma cells, to name a few. Additionally, identifying safe, effective therapeutics for malignant tumors has long been an active area of research. CPPs can circumvent many of the complications found in treating cancer with conventional therapeutics by targeted delivery of drugs into tumors, thereby decreasing off-target side effects, a feat not achievable by currently employed conventional chemotherapeutics. Myriad types of chemotherapeutics such as tyrosine kinase inhibitors, antitumor antibodies and nanoparticles can be functionally attached to these peptides, leading to the possibility of delivering established and novel cancer therapeutics directly to tumor tissue. While much research is needed to overcome potential issues with these peptides, they offer a significant advancement over current mechanisms to treat cancer. In this review, we present a brief overview of the research, leading to identification of CPPs with a comprehensive state-of-the-art review on the role of these novel peptides in both cancer diagnostics as well as therapeutics.

Peptide-based targeted therapeutics and apoptosis imaging probes for cancer therapy

Recent Development on Peptide-Based Probes for Multifunctional Biomedical Imaging

Novel Peptide Therapeutic Approaches for Cancer Treatment

Peptide-Based Therapeutics in Cancer Therapy

Peptide Therapeutics: Unveiling the Potential against Cancer—A Journey through 1989

Peptide-Based Strategies for Targeted Tumor Treatment and Imaging

Peptides-based therapy and diagnosis. Strategies for non-invasive therapies in cancer

Cell-Penetrating Peptides: Applications in Tumor Diagnosis and Therapeutics

Peptide-Conjugated Nano Delivery Systems for Therapy and Diagnosis of Cancer

Applications of Peptide-based Nanomaterials in Targeting Cancer Therapy

Peptide-Based Bioconjugates and Therapeutics for Targeted Anticancer Therapy

Peptide‐Based Multifunctional Nanomaterials for Tumor Imaging and Therapy

Anti-cancer peptide-based therapeutic strategies in solid tumors

Peptide-Enabled Targeted Delivery Systems for Therapeutic Applications

Cancer Treatment Using Peptides: Current Therapies and Future Prospects

Role of Functionalized Peptides in Nanomedicine for Effective Cancer Therapy

Peptide-based nanoprobes for molecular imaging and disease diagnostics

Peptide-Drug Conjugates: A New Hope for Cancer Management

The Potential Use of Peptides in Cancer Treatment

Peptide-conjugated Nanoparticles for Targeted Imaging and Therapy of Prostate Cancer

Construction of Targeting-Peptide-Based Imaging Reagents and Their Application in Bioimaging